Biostem Technologies Inc
OTC:BSEM

Watchlist Manager
Biostem Technologies Inc Logo
Biostem Technologies Inc
OTC:BSEM
Watchlist
Price: 17.41 USD -25.47% Market Closed
Market Cap: 284.5m USD
Have any thoughts about
Biostem Technologies Inc?
Write Note

Biostem Technologies Inc
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Biostem Technologies Inc
Cost of Revenue Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Biostem Technologies Inc
OTC:BSEM
Cost of Revenue
-$1.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Cost of Revenue
-$27B
CAGR 3-Years
3%
CAGR 5-Years
0%
CAGR 10-Years
-2%
Bristol-Myers Squibb Co
NYSE:BMY
Cost of Revenue
-$11.4B
CAGR 3-Years
-6%
CAGR 5-Years
-10%
CAGR 10-Years
-11%
Pfizer Inc
NYSE:PFE
Cost of Revenue
-$17.5B
CAGR 3-Years
10%
CAGR 5-Years
N/A
CAGR 10-Years
-6%
Merck & Co Inc
NYSE:MRK
Cost of Revenue
-$14.8B
CAGR 3-Years
-2%
CAGR 5-Years
-2%
CAGR 10-Years
2%
Eli Lilly and Co
NYSE:LLY
Cost of Revenue
-$7.8B
CAGR 3-Years
-4%
CAGR 5-Years
-11%
CAGR 10-Years
-4%

See Also

What is Biostem Technologies Inc's Cost of Revenue?
Cost of Revenue
-1.3m USD

Based on the financial report for Dec 31, 2023, Biostem Technologies Inc's Cost of Revenue amounts to -1.3m USD.

What is Biostem Technologies Inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 1Y
17%

Over the last year, the Cost of Revenue growth was 17%.

Back to Top